Overview
Background
Dr Yuao Wu is a Research Fellow specializing in nanotechnology, nanosensors, and theranostic medicine. He obtained his PhD in Biomedical Engineering from the Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland (UQ) in 2021 , after completing a Master of Biotechnology at UQ in 2016. His research expertise lies in nanotechnology-enabled molecular bioanalysis, single-particle detection, and the deep molecular profiling of extracellular vesicles (EVs). He has established a strong academic track record in advancing diagnostic nanotechnologies, having published over 30 peer-reviewed papers that have attracted more than 1,200 citations(h-index 20). Actively engaged in national scientific leadership, he serves as the Secretary of the Australian Society of Molecular Imaging (ASMI). Alongside his research, he provides continuous academic mentoring to his research group and co-supervises multiple PhD students developing nanotechnological strategies to detect and treat cardiovascular and inflammatory diseases.
Expertise:
-
Nanomaterial Engineering: Surface engineering and functionalization of nanoparticles and liposomes.
-
Advanced Analysis & Imaging: High-resolution single-particle analysis and advanced fluorescence imaging.
-
Translational Disease Models: Complex in vitro cell culture (including 3D models) and in vivo preclinical models for cardiovascular and inflammatory diseases.
Availability
- Dr Yuao Wu is:
- Available for supervision
Qualifications
- Bachelor of Biomolecular Science, Griffith University
- Masters (Coursework) of Biotechnology, The University of Queensland
- Doctor of Philosophy of Biomedical Engineering, The University of Queensland
Research interests
-
Extracellular vesicles (EVs)
-
Nanosensors
-
Anti-ROS
-
Cardiovascular disease
-
Theranostics
Research impacts
Dr Wu's research bridges the gap between fundamental nanotechnology and real-world medical applications, aiming to alleviate the global health burden of chronic inflammatory conditions, cardiovascular diseases, and neurodegenerative disorders. By developing highly sensitive, single-particle analytical platforms and targeted nanomedicines, his work provides crucial tools for the early detection and understanding of diseases like atherosclerosis and Alzheimer's.
The impacts of Dr Wu's research activities include:
-
Clinical Translation: Developing highly sensitive diagnostic platforms and targeted nanomedicines to accelerate the journey from laboratory bench to real-world medical applications.
-
Global Scientific Influence: Published 30+ peer-reviewed papers with over 1,200 citations (h-index 20), demonstrating widespread international adoption of his technical solutions.
-
National Leadership: Driving cross-institutional collaboration and knowledge exchange across Australia as the Secretary of the Australian Society of Molecular Imaging (ASMI).
-
Next-Generation Mentorship: Training future translational scientists through the active supervision of PhD and master's students.
Works
Search Professor Yuao Wu’s works on UQ eSpace
2021
Journal Article
Different approaches to synthesising cerium oxide nanoparticles and their corresponding physical characteristics, and ROS scavenging and anti-inflammatory capabilities
Wu, Yuao and Ta, Hang T. (2021). Different approaches to synthesising cerium oxide nanoparticles and their corresponding physical characteristics, and ROS scavenging and anti-inflammatory capabilities. Journal of Materials Chemistry B, 9 (36), 7291-7301. doi: 10.1039/d1tb01091c
2020
Journal Article
The choice of targets and ligands for site-specific delivery of nanomedicine to atherosclerosis
Zia, Adil, Wu, Yuao, Nguyen, Tuan, Wang, Xiaowei, Peter, Karlheinz and Ta, Hang T. (2020). The choice of targets and ligands for site-specific delivery of nanomedicine to atherosclerosis. Cardiovascular Research, 116 (13), 2055-2068. doi: 10.1093/cvr/cvaa047
2020
Journal Article
The Role of Toll-like Receptors in Atherothrombotic Cardiovascular Disease
Zhou, Ying, Little, Peter J., Downey, Liam, Afroz, Rizwana, Wu, Yuao, Ta, Hang T., Xu, Suowen and Kamato, Danielle (2020). The Role of Toll-like Receptors in Atherothrombotic Cardiovascular Disease. ACS Pharmacology & Translational Science, 3 (3) acsptsci.9b00100, 457-471. doi: 10.1021/acsptsci.9b00100
2019
Journal Article
Investigating the use of layered double hydroxide nanoparticles as carriers of metal oxides for theranostics of ROS-related diseases
Liu, Yajun, Wu, Yuao, Zhang, Run, Lam, Jacinta, Ng, Jack C., Xu, Zhi Ping, Li, Li and Ta, Hang T. (2019). Investigating the use of layered double hydroxide nanoparticles as carriers of metal oxides for theranostics of ROS-related diseases. ACS Applied Bio Materials, 2 (12) acsabm.9b00852, 5930-5940. doi: 10.1021/acsabm.9b00852
Supervision
Availability
- Dr Yuao Wu is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Media
Enquiries
For media enquiries about Dr Yuao Wu's areas of expertise, story ideas and help finding experts, contact our Media team: